- Home
- USIO vs RNXT Comparison
USIO vs RNXT Comparison
Compare USIO & RNXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | USIO | RNXT |
|---|---|---|
| Founded | 1998 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Bankers/Brokers/Service | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 83.5M | 79.4M |
| IPO Year | 1999 | 2021 |
Fundamental Metrics
Financial Performance| Metric | USIO | RNXT |
|---|---|---|
| Price | $2.82 | $1.14 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 4 |
| Target Price | $5.92 | ★ $7.13 |
| AVG Volume (30 Days) | 197.7K | ★ 523.1K |
| Earning Date | 11-11-2026 | 11-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 20.00 |
| EPS | ★ 0.01 | N/A |
| Revenue | ★ $28,200,535.00 | $1,123,000.00 |
| Revenue This Year | $14.57 | $244.84 |
| Revenue Next Year | $11.98 | $195.26 |
| P/E Ratio | $285.50 | ★ N/A |
| Revenue Growth | 12.69 | ★ 2511.63 |
| 52 Week Low | $1.03 | $0.70 |
| 52 Week High | $3.06 | $2.59 |
Technical Indicators
Market Signals| Indicator | USIO | RNXT |
|---|---|---|
| Relative Strength Index (RSI) | 56.50 | 33.49 |
| Support Level | $2.15 | $0.83 |
| Resistance Level | $3.03 | $1.28 |
| Average True Range (ATR) | 0.17 | 0.10 |
| MACD | 0.01 | -0.04 |
| Stochastic Oscillator | 67.74 | 12.73 |
Price Performance
Historical ComparisonAbout USIO Usio Inc.
Usio Inc is a cloud-based Fintech payment processor. The company serves multiple industry verticals with technology that facilitates payment acceptance and funds disbursement in a single, full-stack ecosystem. It provides payment acceptance through multiple payment methods, including payment facilitation, prepaid card, and electronic billing products and services to businesses, merchants, and consumers. The company's reportable operating segments are Output Solutions and Merchant Services, and these segments.
About RNXT RenovoRx Inc.
RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical needs with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed for targeted therapeutic delivery across the arterial wall near the tumor site (known as intra-arterial, or IA delivery) to bathe the target tumor, while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.